行情

OPK

OPK

OPKO Health
NASDAQ

实时行情|Nasdaq Last Sale

1.560
-0.030
-1.89%
盘后: 1.560 0 0.00% 19:51 01/17 EST
开盘
1.610
昨收
1.590
最高
1.630
最低
1.560
成交量
364.69万
成交额
--
52周最高
3.870
52周最低
1.330
市值
10.38亿
市盈率(TTM)
-3.2629
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

OPK 新闻

  • 去年中国吸收外资1400亿美元 仍是第二大外资流入国
  • 新华社.4小时前
  • 人脸识别技术该不该禁止?谷歌与微软各执一词
  • 新浪科技.4小时前
  • 隔夜要闻:美股周一休市 财报季进入白热化阶段在即
  • 新浪美股.5小时前
  • 供应充足预期冲淡利比亚局势影响 油价微涨
  • 新浪美股.6小时前

更多

所属板块

制药
+0.13%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

OPK 简况

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.
展开

Webull提供Opko Health Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。